Piramal Pharma has informed that as per the information received by the Company on July 08, 2025, NSE Sustainability Ratings and Analytics (‘NSE Sustainability’), has assigned an Environment, Social, and Governance (‘ESG’) Rating of ‘61’ for the Company for the FY 2023-24 based on data made available by the Company in public domain for that year. The link for the rating as published is also available on the website of NSE Sustainability - NSE Sustainability Ratings & Analytics. Please note that the Company has not engaged NSE Sustainability for ESG Rating. NSE Sustainability has voluntarily prepared the report considering the ESG factors reported by the Company.
The above information is a part of company’s filings submitted to BSE.
